**Introduction:** Antisynthetase syndrome (anti-SS) is a rare autoimmune disorder characterised by autoantibodies against aminoacyl tRNA synthetases, in conjunction with interstitial lung disease, dermatomyositis or polymyositis. We present an interesting case of pregnancy in a woman with known anti-SS with anti Ro antibodies, and the associated management principles.

**Case description:** A 36 year old woman was diagnosed with anti-SS in 2014, having presented with severe myositis and fever. She was found to be positive for anti Jo-1, Ro and PM-Scl-75 antibodies and have mild interstitial lung disease. Medical history included depression and osteopenia. She became pregnant in 2016, having previously been seen in prepregnancy counselling when her medication had been optimised prior to pregnancy. She was booked for antenatal care under the high risk maternal medicine team at a tertiary referral unit with input from Obstetric Medicine. In early pregnancy, she was talking prednisolone 5mg once a day, azathioprine 125mg once a day, ranitidine 150mg nocte, folic acid 5mg and high dose vitamin D3. She stopped ibuprofen and started paracetamol, and reduced sertraline from 100mg to 50mg daily. At 12 weeks\' gestation, she was commenced on aspirin 75mg nocte. Blood tests including renal function and CRP, lung function tests and an echocardiogram were all normal. A fetal cardiac scan and oral glucose tolerance test (OGTT) were both normal at 16 weeks. Rheumatology input was arranged. Due to the presence of anti-Ro antibodies, the risk of neonatal lupus and congenital heart block were discussed. In addition to the fetal cardiac scan, weekly fetal heart monitoring and rate recording from 20 weeks\' gestation was arranged, which was normal. She experienced protracted nausea and vomiting which was treated with antiemetics. She was reviewed by both the Obstetric and Rheumatology teams at 28 weeks\' gestation. She had no issues with her skin, joints or muscles, but was found to be lymphopenic (0.28 units) thus her azathioprine was reduced to 100mg daily. Repeat OGTT was normal and her vomiting was much improved. She was reviewed in the obstetric anaesthetic clinic in view of her ILD and muscle weakness and was deemed low anaesthetic risk. She remained well at 32 weeks\' gestation on the reduced dose of azathioprine. Repeat fetal echocardiogram was normal. She developed an iron deficiency anaemia which was treated with parenteral iron at 34 weeks\' gestation. Fetal growth scan at 36 weeks\' was normal. At 38 weeks\' gestation she required antibiotic treatment for asymptomatic bacteriuria. She presented in spontaneous labour at term and was given intrapartum intravenous hydrocortisone cover. She delivered a baby boy of normal birth weight by emergency caesarean section, for failure to progress in the second stage of labour. The postnatal period was uneventful.

**Discussion:** This is a the first reported case of anti-SS in pregnancy which provides a unique opportunity to discuss the medication and management principles of pregnancy specific to anti-SS, but which are largely extrapolated from women with other types of connective tissue disease. Input from experts in the field regarding both maternal and fetal implications of this rare connective tissue disorder would stimulate an interesting and informative discussion.

**Key learning points:** 1. Prepregnancy counselling for women with connective tissue disease is of utmost importance to optimise medication and plan a pregnancy whilst the disease is quiescent. This is associated with improved outcomes for both mother and baby. 2. Patient compliance with immunosuppressant medication should be emphasised to reduce the disease burden associated with flares during pregnancy. 3. A multidisciplinary care model in pregnancy is ideal for women with rare autoimmune connective tissue disorders such as antisynthetase syndrome. This should include, but would not be limited to, input from Rheumatologists, Obstetric Physicians, Obstetricians, Specialists Midwives, Anaesthetists and Fetal Cardiologists.
